MEAGAN CARROLL: Open Payments
NPI 1346750510 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 27 payments from 11 companies in 2025. Trend: 2023 $219 · 2024 $259 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $144 |
| Novo Nordisk Inc | 3 | $85 |
| Actelion Pharmaceuticals US, Inc. | 3 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Exact Sciences Corporation | 3 | $64 |
| Amgen Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $48 |
| ABBVIE INC. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| PFIZER INC. | 1 | $27 |
Products named: SHINGRIX, Wegovy, FANAPT, Cologuard Collection Kit, OPSUMIT, MOUNJARO, AREXVY, Repatha.
Industry payments across CT — which companies pay providers there.
